CClinicalTrials.gg
CompletedNCT02731963Updated Apr 8, 2016

Mechanical Bowel Preparation for Elective Colorectal Anastomosis

A Phase 3 interventional study of Polyethylene glycol in Anastomosis, sponsored by Instituto Mexicano del Seguro Social. Completed at 1 site in Mexico. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2016-04-08.

Sponsored by Instituto Mexicano del Seguro Social · Phase 3, Interventional, and Prevention

Phase
Phase 3
Study type
Interventional
Enrollment
81
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Colorectal surgery is highly associated with septic complications, therefore, multiple approaches have been used to reduce this complications, one of the most used is mechanical bowel preparation. Lately multiple studies have suggested that mechanical bowel preparation might not be necessary.

Read the detailed description

Objective: Compare elective colorectal anastomosis with or without mechanical bowel preparation on outcomes, particularly anastomotic leak, surgical site infection, and ileum.

Materials and methods: A clinical trial was conducted including patients with colorectal pathology who underwent elective colorectal anastomosis. Patients were randomized into two groups; with mechanical bowel preparation (Group 1), and without mechanical bowel preparation (Group 2). Surgical, and non-surgical outcomes were evaluated, including anastomotic leak, surgical site infection, ileum, acute kidney injury, pneumonia, and mortality.

The statistical analysis was performed according to the nature of variables, for continuous data using measures of central tendency and dispersion and for the qualitative data with frequencies and percentages. Inferential analysis with student's t-test, and/or Mann-Whitney's U test; chi-square distribution, and/or Fisher's exact test respectively.

02

Conditions studied

  • Anastomosis

Keywords

  • Outcomes
  • Bowel preparation
03

In context

Lead sponsor

Instituto Mexicano del Seguro Social is the lead sponsor of 124 studies on the registry; 21 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Entitlement to the Mexican Institute of Social Security
  • Signed informed consent
  • Patients with colorectal pathology who needed primary elective colorectal anastomosis
  • Body mass index >18, and \< 31

Exclusion criteria

Exclusion Criteria:

  • Patients who dropped out from the study or withdrew the informed consent
  • Patients who did not accepted the surgical procedure
  • Patients who had been submitted to surgery before entering the protocol
  • Patients who need a colostomy
05

Study design

Phase
Phase 3
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
81 participants (actual)

Study arms

  • Experimental
    Mechanical bowel preparation

    80 Patients who received mechanical bowel preparation with 4 packets of polyethylene glycol in 4 liters of water, 4 hours before intervention.

    Drug: Polyethylene glycol

  • No intervention
    No mechanical bowel preparation

    81 Patients who received clear liquid diet 1 day before intervention.

Interventions

  • DrugPolyethylene glycol

    Patients with colorectal pathology who underwent elective colorectal anastomosis, that were randomized into two groups; one of them received mechanical bowel preparation with polyethylene glycol (study group), and the other one received clear liquid diet(control group) .

06

What researchers measure

Primary outcomes

  1. Number of Participants with Anastomotic leak

    Following the surgical procedure, anastomotic leak was evaluated with fecal discharge on drainage and confirmed with computerized tomography.

    Time frame: 6 weeks

  2. Number of Participants with Surgical site infection

    Following the surgical procedure, surgical site infection was evaluated if the patient presented specific signs and symptoms for this condition (redness, delayed healing, fever, pain, tenderness, warmth, or swelling), and confirmation with culture of the purulent discharge.

    Time frame: 6 weeks

  3. Number of Participants with Postoperative ileus

    Following the surgical procedure, ileus was evaluated if the patient presented distended and tympanic abdomen, and absence or hypoactive bowel sounds, and confirmed with a plain abdominal radiography.

    Time frame: 6 weeks

Secondary outcomes

  1. Number of Participants with Fistula

    Following the surgical procedure, fistula was evaluated with fecal discharge on drainage and confirmed with CT fistulography.

    Time frame: 6 weeks

  2. Number of Participants with Abdominal sepsis

    Following the surgical procedure, abdominal sepsis was evaluated if the patient presented specific signs and symptoms for this condition (fever, abdominal pain, ascites, worsening), and confirmation with computerized tomography.

    Time frame: 6 weeks

  3. Number of Participants with Abscess

    Following the surgical procedure, abscesses were evaluated if the patient presented specific signs and symptoms for this condition (fever, abdominal pain, ascites), and confirmation with computerized tomography.

    Time frame: 6 weeks

  4. Number of Participants with Pneumonia

    Following the surgical procedure, pneumonia was evaluated if the patient presented specific signs and symptoms for this condition (fever, shaking chills, cough productive of sputum), and confirmation with chest radiography.

    Time frame: 6 weeks

  5. Number of Participants with Acute kidney injury

    Following the surgical procedure, acute kidney injury was evaluated with kidney function studies (BUN, creatinine)

    Time frame: 6 weeks

07

Study locations

1 site
  • Western Medical Center, Mexican Institute of Social Security
    Guadalajara, Jalisco 44340, Mexico
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 8, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02731963
Lead sponsor
Instituto Mexicano del Seguro Social
Responsible party
CLOTILDE FUENTES OROZCO (PhD, Instituto Mexicano del Seguro Social) — Principal investigator
First posted
Apr 8, 2016
Start date
Sep 2014
Primary completion
Feb 2015
Completion
Feb 2016
Last update
Apr 8, 2016

Study contacts

Clotilde Fuentes, PhD
principal investigator · Instituto Mexicano del Seguro Social

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion